SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-21-011697
Filing Date
2021-11-04
Accepted
2021-11-04 16:56:08
Documents
4
Period of Report
2021-10-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 2126
2 POWER OF ATTORNEY tenax-poalurier.htm EX-24 2469
3 IMAGE tenax-poalurier000.jpg GRAPHIC 97415
4 IMAGE tenax-poalurier001.jpg GRAPHIC 32822
  Complete submission text file 0001654954-21-011697.txt   185916
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452
Business Address
Lurier Eliot M (Reporting) CIK: 0001438037 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 211380875